SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Zonagen (zona) - good buy?

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Linda Kaplan who wrote (3290)4/2/1998 6:24:00 PM
From: Dauntless  Read Replies (1) of 7041
 
Linda, regarding the stock purchases

The following is from the earnings press release

<<<At December 31, 1997, the Company reported a cash balance of $73,761,823. As of December 31, 1997 common shares outstanding were 11,480,423. On December 12, 1997 the Company announced that the Board of Directors had authorized it to repurchase up to $10,000,000 of common stock. As of March 30, 1998 the Company had repurchased 288,300 shares (including 61,500 shares repurchased in December 1997) at an aggregate average price of $18.42 per share. As of March 30, 1998 Zonagen had approximately $62 million in cash and 11.3 million shares outstanding.>>>

This should clear up some of the questions regarding number of shares purchased by 3/30, cash burns & balances. They went through 12 million in the first qtr. compared to ~$10 million in 4th qtr 97. Looks like they spent $5 million for the stock they purchased.

Don't think they've been playing the game your describing, IMHO.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext